Find Grants for School Districts
Find out if you qualify for verified grants for School Districts. Discover your eligibility and key funding details for School Districts from major foundations and government agencies.
D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
Deadline: September 7, 2027
Opportunity Number: PAS-25-236
Agency: National Institutes of Health
Open Date: December 16, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.279
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
Deadline: November 15, 2027
Opportunity Number: PAR-25-311
Agency: National Institutes of Health
Open Date: December 16, 2024
Close Date: November 15, 2027
Status: Posted
CFDA Numbers: 93.865, 93.313
NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
Deadline: October 12, 2027
Opportunity Number: RFA-DC-25-002
Agency: National Institutes of Health
Open Date: December 16, 2024
Close Date: October 12, 2027
Status: Posted
CFDA Numbers: 93.173
Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
Deadline: February 26, 2027
Opportunity Number: RFA-HG-25-009
Agency: National Institutes of Health
Open Date: December 16, 2024
Close Date: February 26, 2027
Status: Posted
CFDA Numbers: 93.172
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
Deadline: November 15, 2027
Opportunity Number: PAR-25-336
Agency: National Institutes of Health
Open Date: December 16, 2024
Close Date: November 15, 2027
Status: Posted
CFDA Numbers: 93.395
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
Deadline: September 25, 2026
Opportunity Number: PAR-25-247
Agency: National Institutes of Health
Open Date: December 13, 2024
Close Date: September 25, 2026
Status: Posted
CFDA Numbers: 93.866
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Deadline: September 10, 2027
Opportunity Number: PAR-25-325
Agency: National Institutes of Health
Open Date: December 13, 2024
Close Date: September 10, 2027
Status: Posted
CFDA Numbers: 93.393
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
Deadline: May 8, 2027
Opportunity Number: PAR-25-317
Agency: National Institutes of Health
Open Date: December 13, 2024
Close Date: May 8, 2027
Status: Posted
CFDA Numbers: 93.313, 93.307, 93.399, 93.273, 93.310, 93.361
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-346
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.394, 93.393, 93.121, 93.396, 93.395, 93.399
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
Deadline: July 16, 2026
Opportunity Number: PAR-25-154
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: July 16, 2026
Status: Posted
CFDA Numbers: 93.853, 93.846, 93.273, 93.865, 93.866, 93.121, 93.213, 93.279, 93.350
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
Deadline: October 19, 2026
Opportunity Number: PAR-25-155
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: October 19, 2026
Status: Posted
CFDA Numbers: 93.350
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
Deadline: June 18, 2026
Opportunity Number: PAR-25-157
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: June 18, 2026
Status: Posted
CFDA Numbers: 93.350
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-321
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.394, 93.395, 93.393, 93.399, 93.396
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
Deadline: June 15, 2026
Opportunity Number: RFA-EY-25-001
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: June 15, 2026
Status: Posted
CFDA Numbers: 93.173, 93.286, 93.213, 93.865, 93.866, 93.853, 93.867, 93.273, 93.242, 93.279
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline: November 2, 2026
Opportunity Number: PAR-24-280
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.846
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline: November 2, 2026
Opportunity Number: PAR-24-279
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.846
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: March 4, 2027
Opportunity Number: PAR-25-141
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: March 4, 2027
Status: Posted
CFDA Numbers: 93.846
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
Deadline: September 7, 2027
Opportunity Number: PAR-24-330
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.273, 93.866, 93.853, 93.361, 93.399, 93.837, 93.840, 93.233, 93.307
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-100
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.279
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Deadline: June 2, 2026
Opportunity Number: RFA-TR-25-002
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: June 2, 2026
Status: Posted
CFDA Numbers: 93.350
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-055
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-056
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-299
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.273, 93.307, 93.399
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-025
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.233, 93.837
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-026
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838
